Other or ill-defined heart diseases

I9_OTHILLHEART

heart disease: A disease involving the heart and/or pericardium.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I51, I52* Hospital discharge: ICD-9 — 429 Hospital discharge: ICD-8 — 42899\|42999 Cause of death: ICD-10 — I51, I52* Cause of death: ICD-9 — 429 Cause of death: ICD-8 — 42899\|42999 2 out of 7 registries used, show all original rules.	2448
4. Check minimum number of events None	2448
5. Include endpoints None	2448
6. Filter based on genotype QC (FinnGen only)	2375

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	I9_OTHILLHEART
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I5[1-2]
HD_ICD_9	429
HD_ICD_8	42899\|42999
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I5[1-2]
COD_ICD_9	429
COD_ICD_8	42899\|42999
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other or ill-defined heart diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	33677	12205	20779
Only index persons	17579	6000	11579
Unadjusted period prevalence (%)
Whole population	0.50	0.35	0.58
Only index persons	0.37	0.22	0.44
Median age at first event (years)
Whole population	58.86	65.01	55.08
Only index persons	51.92	58.39	48.57

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2375	875	1500
Unadjusted period prevalence (%)	0.55	0.31	0.69
Median age at first event (years)	56.01	56.01	56.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2446: Matched controls
24452

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

119.7

308.8

157

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

119.7

308.8

157

I50.9

ICD-10 Finland

Heart failure, unspecified

83.9

307.7

507

C01AA05

ATC

digoxin; systemic

17.6

307.7

273

173

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

6.1

307.7

841

1921

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

9.4

307.7

787

1171

I50.0

ICD-10 Finland

Congestive heart failure

182.6

307.7

290

207

Kela drug reimbursment

Chronic arrhythmias

190.1

307.7

385

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

173.1

307.7

249

B01AA03

ATC

warfarin; systemic

8.6

307.7

653

992

I48

ICD-10 Finland

Atrial fibrillation and flutter

98.1

307.7

567

201

Kela drug reimbursment

Chronic cardiac insufficiency

22.1

307.7

301

154

I51.7

ICD-10 Finland

Cardiomegaly

+∞

307.7

554

I51.4

ICD-10 Finland

Myocarditis, unspecified

7060.8

307.7

928

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

284.7

307.7

300

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

7.7

307.7

813

1482

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

289.4

272

C07AB07

ATC

bisoprolol; oral

4.2

272.0

1336

5416

C03CA01

ATC

furosemide; systemic

4.6

271.7

915

2819

I50.1

ICD-10 Finland

Left ventricular failure

1427.2

267.6

256

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

92.9

252.4

132

C03DA01

ATC

spironolactone; oral

6.6

234.0

418

736

XF404

NOMESCO Finland

Ambulatory ECG

10.7

225.8

257

265

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

48.0

203.6

119

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

294.8

188.8

190

I51.9

ICD-10 Finland

Heart disease, unspecified

629.4

180.0

176

TFP20

NOMESCO Finland

Cardiodefibrillation

242.6

176.9

180

K78

ICPC

Atrial fibrillation/flutter

16.9

171.5

145

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

+∞

169.8

161

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.1

162.1

534

1557

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

155.9

148

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

+∞

152.7

145

AN1

Coronary angiography

5.0

151.9

366

835

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

326.4

151.5

152

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

6.6

149.9

257

428

B01AF02

ATC

apixaban; oral

7.4

146.6

224

330

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

7.6

144.7

215

307

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

142.6

1203

6133

I35.0

ICD-10 Finland

Aortic (valve) stenosis

25.5

139.6

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

57.5

138.4

I49.3

ICD-10 Finland

Ventricular premature depolarization

10.1

137.8

160

168

I51.8

ICD-10 Finland

Other ill-defined heart diseases

+∞

126.1

120

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

639.6

124.4

122

R07.4

ICD-10 Finland

Chest pain, unspecified

2.9

119.5

789

3469

I50

ICD-10 Finland

Heart failure

30.9

114.2

C01BD01

ATC

amiodarone; systemic

138.9

112.1

119

GD1LA

NOMESCO Finland

44.5

109.3

42999

ICD-8 Finland

Ill-defined heart disease, Other and unspecified heart disease

+∞

108.1

103

I47.1

ICD-10 Finland

Supraventricular tachycardia

26.8

106.1

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

4.9

102.1

243

543

I51.1

ICD-10 Finland

Rupture of chordae tendineae, not elsewhere classified

+∞

101.8

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

518.7

101.3

100

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.9

97.4

588

2431

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

96.9

477

1760

I47.2

ICD-10 Finland

Ventricular tachycardia

199.7

93.0

C09AA05

ATC

ramipril; oral

2.7

90.9

650

2921

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

5.0

90.7

205

438

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

90.1

XF402

NOMESCO Finland

ECG with work load test

4.0

90.0

275

744

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

141.1

89.7

R06.0

ICD-10 Finland

Dyspnoea

2.6

87.4

641

2909

ZXD05

NOMESCO Finland

Urgent procedure

2.4

83.2

799

4098

I44.2

ICD-10 Finland

Atrioventricular block, complete

825.0

81.9

FL1AC

NOMESCO Finland

Left cardioangiography

12.7

80.6

TFP34

NOMESCO Finland

Electrophysiological investigation

254.1

72.7

C07AA07

ATC

sotalol; systemic

8.2

71.4

121

I49.5

ICD-10 Finland

Sick sinus syndrome

100.7

71.3

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

6.9

69.0

108

162

Angiography of the heart and coronary arteries

4.4

68.6

182

441

I48.2

ICD-10 Finland

Chronic atrial fibrillation

182.7

68.4

WX892

NOMESCO Finland

Monitored bed care

3.8

67.5

219

615

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

7.9

65.6

119

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

5.1

61.8

135

279

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

61.7

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

29.8

61.6

K77

ICPC

Heart failure

24.3

60.3

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

8.6

59.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

59.7

659

3506

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

59.6

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

581.3

57.9

WX872

NOMESCO Finland

Intensive care

4.6

56.5

140

321

I34.1

ICD-10 Finland

Mitral (valve) prolapse

80.9

56.2

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

122.9

56.0

A12BA01

ATC

potassium chloride; oral

4.9

55.7

127

272

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

7.8

54.5

100

42899

ICD-8 Finland

Other myocardial insufficiency

+∞

53.3

I48.1

ICD-10 Finland

Persistent atrial fibrillation

116.7

53.0

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

52.3

L04AA06

ATC

mycophenolic acid; systemic

6.9

52.3

120

I51.5

ICD-10 Finland

Myocardial degeneration

+∞

51.2

TK800

NOMESCO Finland

Hemodialysis

6.6

50.8

130

C07AB02

ATC

metoprolol; systemic

2.3

50.4

452

2192

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

260.6

50.3

4298A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[ASTHENIA VASOREGULATORIA]

+∞

50.2

AP1

Catheterization of the left side of the heart

9.6

49.9

I25.2

ICD-10 Finland

Old myocardial infarction

3.5

49.3

183

560

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.3

49.1

438

2117

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

49.1

173

512

C01BC04

ATC

flecainide; systemic

132.7

49.0

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

7.7

48.5

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

48.4

543

2877

I51.0

ICD-10 Finland

Cardiac septal defect, acquired

+∞

48.1

C09DX04

ATC

valsartan and sacubitril; oral

+∞

48.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

48.0

388

1796

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

47.1

189

607

XF640, ,

NOMESCO Finland

8.0

46.9

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

46.0

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

46.0

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

14.9

46.0

I20.09

ICD-10 Finland

Unstable angina

3.8

45.7

147

409

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

45.6

189

619

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.2

44.8

127

XFE00

NOMESCO Finland

Epicardial ultrasonography

7.7

44.2

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

229.0

44.1

C01DA14

ATC

isosorbide mononitrate; oral

2.4

43.9

355

1639

250, ,

Kela drug reimbursment

119.7

43.9

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

8.0

43.5

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

9.6

43.4

TFJ02

NOMESCO Finland

Muscle biopsy of heart

435.0

43.3

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

42.8

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

42.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

42.3

279

1172

5253

FHL

Cardiac lung machine

12.2

42.0

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

41.8

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

41.8

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

414.3

41.2

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

5.3

41.2

163

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

112.0

40.8

4294A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Functional disturbances following cardiac surgery

+∞

40.7

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

40.6

488

2635

C08DA01

ATC

verapamil; systemic

4.6

40.5

216

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

40.4

380

1866

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

9.1

39.9

127

Kela drug reimbursment

Transplant complication

6.6

39.6

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.7

39.5

133

H02AB06

ATC

prednisolone; systemic

1.8

39.2

1047

7289

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

39.1

319

1475

I44.1

ICD-10 Finland

Atrioventricular block, second degree

87.6

38.9

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.4

37.8

138

417

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.7

36.9

220

878

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

36.5

AA1AD

NOMESCO Finland

CT of head and brain

1.9

36.5

581

3444

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

36.1

447

2430

M04AA01

ATC

allopurinol; systemic

2.3

35.6

292

1350

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

9.7

35.1

K84

ICPC

Heart disease other

6.0

34.8

106

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

33.5

247

1089

AS4

Physiological pacemaker insertion DDD (R)

+∞

33.4

L04AX01

ATC

azathioprine; systemic

3.3

33.1

127

396

ZX120

NOMESCO Finland

Intravenous

2.5

32.4

226

972

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

321.0

31.9

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.8

31.8

153

L04AD02

ATC

tacrolimus; systemic

7.2

31.8

TFP35

NOMESCO Finland

Electroanatomical mapping

114.9

31.7

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.0

31.7

229

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

36.9

31.5

Z2221

NOMESCO Finland

Medical doctor

1.8

31.3

583

3608

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

39.6

31.2

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

5.4

31.1

118

R4110

NOMESCO Finland

Physiotherapy

1.8

31.0

590

3674

R07.3

ICD-10 Finland

Other chest pain

2.4

30.8

233

1039

R50.9

ICD-10 Finland

Fever, unspecified

2.0

30.5

353

1865

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

30.3

B33.2

ICD-10 Finland

Viral carditis

83.7

29.8

K80

ICPC

Cardiac arrhythmia NOS

3.1

29.7

128

428

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

29.7

104

306

R02

ICPC

Shortness of breath/dyspnoea

2.3

29.5

250

1170

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

29.2

A02BC02

ATC

pantoprazole; systemic

1.6

29.0

1437

11425

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.9

28.7

223

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.1

28.7

125

421

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

28.2

ZXE00

NOMESCO Finland

One hour or less

1.7

27.9

803

5573

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

8.5

27.9

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.9

27.4

221

N18.8

ICD-10 Finland

Other chronic renal failure

4.8

27.4

132

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

27.3

185

784

B01AB05

ATC

enoxaparin; parenteral

1.7

27.2

607

3934

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

27.1

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

27.1

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

38.3

27.1

N05CF01

ATC

zopiclone; oral

1.7

26.9

708

4795

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.8

26.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

26.7

202

899

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.7

26.7

135

Z94.0

ICD-10 Finland

Kidney transplant status

6.3

26.6

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.1

26.6

112

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.5

26.2

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

26.1

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.2

26.1

108

353

PD5AD

NOMESCO Finland

CT of aorta

5.5

25.7

N05BA01

ATC

diazepam; systemic, rectal

2.0

25.6

303

1610

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

25.4

290

1521

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

5.3

25.3

L04AD01

ATC

ciclosporin; systemic

4.7

25.3

125

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.6

25.2

244

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

25.0

4298X

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[MORBUS CORDIS ALIA DEFINITA]

+∞

25.0

PD5BD

NOMESCO Finland

Extensive CT of aorta

6.0

24.8

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

252.6

24.7

A11CC03

ATC

alfacalcidol; systemic

4.4

24.6

144

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.3

24.6

N18.0

ICD-10 Finland

End-stage renal disease

8.3

24.4

B01AE07

ATC

dabigatran etexilate; oral

4.6

24.3

129

Z94.1

ICD-10 Finland

Heart transplant status

56.6

24.0

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.2

23.9

313

Z3231

NOMESCO Finland

Registered nurse

1.7

23.9

576

3793

1CX08, ,

NOMESCO Finland

87.6

23.7

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

242.2

23.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

23.6

583

3861

H02AB04

ATC

methylprednisolone; systemic

1.9

23.5

302

1648

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

23.4

635

4306

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

23.2

201

946

K70.0

ICD-10 Finland

Alcoholic fatty liver

6.4

23.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

23.0

400

2401

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

22.9

J01MA12

ATC

levofloxacin; systemic

1.8

22.9

391

2335

R00.2

ICD-10 Finland

Palpitations

2.6

22.7

136

543

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

9.4

22.6

WX730

NOMESCO Finland

Conventional respirator

6.0

22.6

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.5

22.5

150

630

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.4

22.3

239

N02AX02

ATC

tramadol; systemic, rectal

1.5

22.2

901

6698

A12AA04

ATC

calcium carbonate; oral

5.2

22.2

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

22.1

212

1040

R03AC02

ATC

salbutamol; inhalant

1.5

22.1

1109

8632

N05BA04

ATC

oxazepam; oral

1.7

22.0

548

3629

I49.1

ICD-10 Finland

Atrial premature depolarization

5.8

22.0

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

21.9

131

522

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

21.9

AQ1

Conventional electrophysiological examination

+∞

21.9

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

5.0

21.8

R00.1

ICD-10 Finland

Bradycardia, unspecified

4.5

21.5

121

R53

ICD-10 Finland

Malaise and fatigue

1.7

21.4

471

3017

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

21.2

213

1063

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

3.0

20.9

333

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

20.9

372

2245

AP4

Myocardial biopsy

+∞

20.9

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

20.9

R55

ICD-10 Finland

Syncope and collapse

2.1

20.8

224

1146

K99

ICPC

Cardiovascular disease other

4.5

20.8

116

J46

ICD-10 Finland

Status asthmaticus

3.9

20.5

161

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

22.5

20.4

H02AB07

ATC

prednisone; oral

1.9

20.3

292

1650

E66.8

ICD-10 Finland

Other obesity

2.8

20.3

106

395

N19

ICD-10 Finland

Unspecified kidney failure

3.3

20.3

229

J01FF01

ATC

clindamycin; systemic

1.6

19.9

541

3650

3AC01, ,

NOMESCO Finland

6.1

19.8

I40.0

ICD-10 Finland

Infective myocarditis

+∞

19.8

K83

ICPC

Heart valve disease NOS

74.1

19.7

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

201.5

19.6

I20.00

ICD-10 Finland

Unstable angina

3.6

19.5

181

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

19.3

757

5550

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

6.5

19.2

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

19.2

435

2802

B01AC04

ATC

clopidogrel; oral

1.8

19.1

309

1809

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.4

19.1

198

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

6.1

19.0

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.3

18.8

142

631

I40.8

ICD-10 Finland

Other acute myocarditis

+∞

18.8

Electrophysiological Special Examination

+∞

18.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

18.8

215

1125

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.5

18.6

121

503

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

18.6

103

396

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.1

18.2

250

Z2446

NOMESCO Finland

Social worker

2.2

18.1

151

700

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

17.9

222

1193

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.0

17.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.9

17.8

4299X

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Heart disease, unspecified

+∞

17.7

I51.6

ICD-10 Finland

Cardiovascular disease, unspecified

+∞

17.7

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

17.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

17.7

132

584

R04.0

ICD-10 Finland

Epistaxis

2.3

17.6

143

656

C09AA02

ATC

enalapril; systemic

1.7

17.5

389

2489

E66.0

ICD-10 Finland

Obesity due to excess calories

6.8

17.4

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

17.4

196

1019

5314

FHL

Bypass surgery for four or more vessels

7.1

17.4

Catheterization and pressure measurement of the left side of the heart

4.6

17.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

16.9

174

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.3

16.8

189

R03BB04

ATC

tiotropium bromide; inhalant

2.0

16.8

204

1088

I44.0

ICD-10 Finland

Atrioventricular block, first degree

14.1

16.8

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

16.8

129

578

C08DB01

ATC

diltiazem; oral

2.5

16.8

108

447

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

16.7

4293A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Cardiomegaly

+∞

16.7

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

16.7

I30.0

ICD-10 Finland

Acute nonspecific idiopathic pericarditis

+∞

16.7

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

16.7

140

651

A46

ICD-10 Finland

Erysipelas

1.8

16.6

281

1667

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

16.5

342

2144

I48.3

ICD-10 Finland

Typical atrial flutter

171.1

16.5

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

16.5

101

408

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

16.5

394

2565

SPAT1097

SPAT

Recording of ECG

1.8

16.3

258

1498

I45.9

ICD-10 Finland

Conduction disorder, unspecified

40.3

16.3

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

16.3

635

4619

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

16.3

282

1683

J01MA14

ATC

moxifloxacin; systemic

2.0

16.2

185

967

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

15.4

16.2

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

4.0

16.0

114

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

15.8

146

705

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.5

15.8

100

411

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

15.7

171

878

B01AF03

ATC

edoxaban; oral

13.0

15.6

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

+∞

15.6

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

+∞

15.6

J01FA06

ATC

roxithromycin; oral

1.5

15.6

783

5979

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

15.6

499

3477

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.9

15.4

190

1019

Z3226

NOMESCO Finland

Physiotherapist

1.6

15.4

356

2295

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

15.2

939

7443

C07AG02

ATC

carvedilol; oral

2.3

15.0

109

477

WX882

NOMESCO Finland

High dependency care

3.2

15.0

193

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

15.0

308

R07.2

ICD-10 Finland

Precordial pain

3.5

14.7

140

WX722

NOMESCO Finland

PEEP

2.5

14.7

370

XF409

NOMESCO Finland

Other special ECG

25.2

14.7

C10AA01

ATC

simvastatin; oral

1.4

14.7

801

6198

M10.9

ICD-10 Finland

Gout, unspecified

2.2

14.6

123

572

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

14.6

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

14.6

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

14.6

I42

ICD-10 Finland

Cardiomyopathy

+∞

14.6

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

150.8

14.5

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

3.5

14.4

142

5315

FHL

Bypass surgery using a mammary artery

5.2

14.4

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.0

14.3

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.8

14.2

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.7

14.2

276

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

14.1

353

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

6.7

14.0

137

Kela drug reimbursment

Uraemia requiring dialysis

5.4

14.0

L04AA01

ATC

[U] ciclosporin

4.7

14.0

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

14.0

119

557

A11

ICPC

Chest pain NOS

2.0

14.0

155

802

K29

ICPC

Cardiovascular sympt/complt other

2.7

13.9

296

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.7

13.9

268

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.9

13.8

224

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

13.8

205

1167

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.0

13.8

UJF32

NOMESCO Finland

Coloscopy

1.5

13.8

481

3404

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

13.7

123

588

J01AA02

ATC

doxycycline; systemic

1.4

13.7

1616

14199

B03XA02

ATC

darbepoetin alfa; parenteral

3.5

13.6

138

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

13.6

683

5191

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

13.6

372

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

13.5

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

13.5

AS2

Ventricular pacemaker insertion VVI (R)

+∞

13.5

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

13.5

I31.8

ICD-10 Finland

Other specified diseases of pericardium

+∞

13.5

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

13.5

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

13.5

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

13.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

13.4

673

5109

N05CD07

ATC

temazepam; oral

1.7

13.4

252

1536

205

Kela drug reimbursment

Chronic hypertension

1.5

13.4

528

3828

K01

ICPC

Heart pain

4.7

13.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

13.3

110

509

WX890

NOMESCO Finland

Intesive care monitoring

6.3

13.3

B01AC06

ATC

acetylsalicylic acid; oral

2.6

13.3

292

A98

ICPC

Health maint/preventive medicine

0.7

13.3

1863

20134

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

13.2

135

678

J96.1

ICD-10 Finland

Chronic respiratory failure

3.4

13.2

136

C08CA05

ATC

nifedipine; systemic

2.1

13.1

125

611

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.9

13.0

210

K07

ICPC

Swollen ankles/oedema

2.5

13.0

313

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

12.8

205

1194

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

12.8

163

885

R03BA01

ATC

beclometasone; inhalant

1.7

12.7

260

1621

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

12.6

119

580

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.5

12.6

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

+∞

12.5

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

12.5

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.2

12.5

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.3

12.5

146

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

12.4

400

J01CA04

ATC

amoxicillin; systemic

1.4

12.4

1721

15391

WX002

NOMESCO Finland

Sedation and analgesia

1.6

12.4

351

2371

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

12.3

341

2290

N06AX11

ATC

mirtazapine; oral

1.4

12.3

647

4943

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.5

12.2

118

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

12.4

12.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

12.0

534

3956

F19.0

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, acute intoxication

46.9

11.9

Coronary artery bypass surgery

3.2

11.8

146

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

9.0

11.7

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

11.7

368

2542

B01AF01

ATC

rivaroxaban; oral

1.8

11.6

171

971

N06AB04

ATC

citalopram; systemic

1.5

11.6

404

2850

G47.3

ICD-10 Finland

Sleep apnoea

1.5

11.5

421

2998

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

11.5

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

+∞

11.5

342

Kela drug reimbursment

Dronedarone

+∞

11.5

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

11.5

7AX01, ,

NOMESCO Finland

+∞

11.5

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

+∞

11.5

I40

ICD-10 Finland

Acute myocarditis

120.5

11.4

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.5

11.4

296

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

11.4

284

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

11.3

397

A10AC01

ATC

insulin (human); parenteral

1.9

11.2

153

848

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.8

11.2

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

11.2

465

N05AA02

ATC

levomepromazine; systemic

2.2

11.2

465

A02BC03

ATC

lansoprazole; oral

1.4

11.1

539

4048

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

11.1

337

2307

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.3

11.1

121

J01DB01

ATC

cefalexin; oral

1.4

11.1

1728

15571

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.8

11.0

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

10.1

11.0

A10BK01

ATC

dapagliflozin; oral

2.0

10.8

121

629

C10AA05

ATC

atorvastatin; oral

1.4

10.8

747

5952

AP2

Catheterization of the right side of the heart

28.1

10.7

B01AB04

ATC

dalteparin; parenteral

2.2

10.7

446

J01DA01

ATC

[U] cefalexin

1.3

10.7

1270

10958

I49

ICD-10 Finland

Other cardiac arrhythmias

4.6

10.7

Q21.10

ICD-10 Finland

Persistent ostium secundum

21.5

10.7

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

21.5

10.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

10.7

1020

8530

C02EA02, ,

ATC

2.2

10.6

415

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.9

10.6

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.4

10.5

110

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

10.5

100

490

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

3.1

10.4

136

I45.3

ICD-10 Finland

Trifascicular block

110.5

10.4

Initial installation of the atrial pacemaker

+∞

10.4

AS7

Arrhythmia pacemaker insertion VVI (R) S

+∞

10.4

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

10.4

Initial pacemaker installation

+∞

10.4

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

+∞

10.4

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

10.4

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

10.4

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

10.4

AA5PD

NOMESCO Finland

CT examination of brain pefusion

5.4

10.4

C07AA05

ATC

propranolol; systemic

1.5

10.4

345

2406

C09AA04

ATC

perindopril; oral

2.2

10.3

426

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

10.3

150

850

S97

ICPC

Chronic ulcer skin

2.1

10.2

100

495

R11

ICD-10 Finland

Nausea and vomiting

1.8

10.2

153

874

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

10.2

111

572

A02BC01

ATC

omeprazole; systemic

1.4

10.1

500

3759

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.3

10.1

113

Q23.11

ICD-10 Finland

Bicuspid aortic valve

14.6

10.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

10.0

232

1493

Catheterization and pressure measurement of the right side of the heart

40.2

10.0

R51.80

ICD-10 Finland

Headache

1.6

9.9

263

1745

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

9.9

255

1682

GD1UN

NOMESCO Finland

Lung circulation SPECT

12.2

9.8

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

9.8

826

6758

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

26.1

9.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

9.8

124

672

GD2SN

NOMESCO Finland

Lung ventilation SPECT

10.7

9.8

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

9.7

174

1046

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.0

9.7

142

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

9.7

257

N05AH04

ATC

quetiapine; oral

1.5

9.7

346

2448

V03AE03

ATC

lanthanum carbonate; oral

13.4

9.7

N03AX16

ATC

[U] pregabalin

1.4

9.7

406

2964

P01AB01

ATC

metronidazole; oral, rectal

1.3

9.6

710

5695

E87.5

ICD-10 Finland

Hyperkalaemia

3.4

9.6

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

3.9

9.6

B05DB

ATC

Hypertonic solutions

5.0

9.6

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

9.5

142

810

R03BA05

ATC

fluticasone; inhalant

1.5

9.5

326

2286

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

9.5

381

I20.01

ICD-10 Finland

Unstable angina

2.7

9.5

189

K04

ICPC

Palpitations/awareness of heart

2.4

9.4

273

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

100.4

9.4

I45.6

ICD-10 Finland

Pre-excitation syndrome

100.4

9.4

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

100.4

9.4

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

100.4

9.4

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

9.4

356

Q21.19

ICD-10 Finland

Atrial septal defect NOS

17.6

9.4

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.1

9.4

129

AP3

Catheterization of the right and left side of the heart

+∞

9.4

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

9.4

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

9.4

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

9.4

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

9.4

AC4

MVP

+∞

9.4

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

+∞

9.4

I40.1

ICD-10 Finland

Isolated myocarditis

+∞

9.4

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

+∞

9.4

FN1AD

NOMESCO Finland

CT of coronary arteries

3.6

9.4

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

9.3

171

1035

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.2

9.3

377

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.0

9.3

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

4.9

9.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

9.3

180

1106

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

4.7

9.3

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

9.3

233

1528

E86

ICD-10 Finland

Volume depletion

2.6

9.2

192

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

9.1

204

R42

ICD-10 Finland

Dizziness and giddiness

1.4

9.1

382

2784

V03AA01, ,

ATC

3.0

9.1

126

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

9.1

503

C02AC05

ATC

moxonidine; oral

2.2

9.1

348

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

9.1

190

1191

AN3

Balloon angioplasty and metallic stent

2.6

9.1

193

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.0

9.1

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

9.0

104

547

H02AB09

ATC

hydrocortisone; systemic

2.6

9.0

194

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.6

8.9

FM1AD

NOMESCO Finland

CT of heart

24.1

8.9

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

8.9

225

A02BC05

ATC

esomeprazole; systemic

1.3

8.9

732

5954

B05DA

ATC

Isotonic solutions

4.5

8.8

SPAT1254

SPAT

Administration of medicine

1.5

8.8

254

1717

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

8.8

118

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.4

8.8

232

J01FA10

ATC

azithromycin; systemic

1.3

8.7

1094

9411

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

50.2

8.7

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

50.2

8.7

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.2

8.6

104

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

8.6

235

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.1

8.6

350

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

8.6

519

4027

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

3.1

8.5

115

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.2

8.5

100

ZX108

NOMESCO Finland

Inhalation

6.4

8.5

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.2

8.4

TK810

NOMESCO Finland

Hemofiltration

7.4

8.4

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

8.4

105

567

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

8.4

160

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

90.3

8.4

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

90.3

8.4

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.9

8.4

C03AA03

ATC

hydrochlorothiazide; oral

1.7

8.4

142

842

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

8.4

428

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.9

8.4

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.0

8.3

122

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

8.3

524

4087

C01BD07

ATC

dronedarone; oral

+∞

8.3

I51.2

ICD-10 Finland

Rupture of papillary muscle, not elsewhere classified

+∞

8.3

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

8.3

Catheter ablation of arrhythmia

+∞

8.3

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

8.3

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

8.3

4240B

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[PROLAPSUS VALVULAE MITRALIS (SYNDROMA BARLOW)]

+∞

8.3

Aortic Valve Replacement (AVR)

+∞

8.3

B04AB02, ,

ATC

2.8

8.3

144

XF620

NOMESCO Finland

Examination of circulation with color method

8.5

8.3

J01MA02

ATC

ciprofloxacin; systemic

1.3

8.3

751

6178

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

8.3

142

845

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

8.2

271

E66.9

ICD-10 Finland

Obesity, unspecified

2.3

8.2

246

J01DA09

ATC

[U] cefadroxil

1.4

8.2

497

3854

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

8.2

222

1481

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

8.2

417

3145

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

7.5

8.1

N17.8

ICD-10 Finland

Other acute renal failure

3.9

8.1

A03

ICPC

Fever

1.5

8.1

298

2116

J45

ICD-10 Finland

Asthma

1.7

8.1

164

1019

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

8.1

331

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

8.1

699

5706

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

8.1

387

2884

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.6

8.1

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

8.1

248

1699

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

8.1

170

1068

V03AE01

ATC

polystyrene sulfonate; oral

3.3

8.1

J81

ICD-10 Finland

Pulmonary oedema

8.9

8.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

8.0

212

N02BE01

ATC

paracetamol; systemic, rectal

1.3

8.0

1837

17000

C09AA01

ATC

captopril; oral

2.9

8.0

120

B04AB01, ,

ATC

3.5

8.0

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

13.1

7.9

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

7.9

166

1044

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

8.5

7.8

78200

ICD-8 Finland

Symptoms referable to cardiovascular and lymphatic system, Precordial pain

9.4

7.8

R07.1

ICD-10 Finland

Chest pain on breathing

3.0

7.8

111

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

7.8

440

R60.0

ICD-10 Finland

Localized oedema

1.6

7.7

191

1248

FM1BG

NOMESCO Finland

MRI examination of heart with high intensity magnet

45.1

7.7

WX740

NOMESCO Finland

Nitrogen oxide therapy

15.1

7.7

WX213

NOMESCO Finland

Lower leg blockade

6.4

7.7

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.4

7.7

216

M05BA04

ATC

alendronic acid; oral

1.7

7.7

145

886

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.4

7.7

N30.0

ICD-10 Finland

Acute cystitis

1.5

7.7

241

1660

JN4AD

NOMESCO Finland

Body CT examination

1.6

7.7

166

1051

X58

ICD-10 Finland

Exposure to other specified factors

1.5

7.5

267

1883

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.5

7.5

R4120

NOMESCO Finland

Occupational therapy

1.8

7.5

114

655

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

7.5

335

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

7.5

166

1056

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

7.5

481

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.7

7.5

147

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.7

7.5

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.1

7.4

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.4

7.4

I44.4

ICD-10 Finland

Left anterior fascicular block

80.3

7.4

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

7.4

533

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

7.4

743

6177

XG466

NOMESCO Finland

Sleep oxymetry

2.3

7.4

220

I97.0

ICD-10 Finland

Postcardiotomy syndrome

13.4

7.4

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

13.4

7.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.4

7.4

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.3

7.4

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.8

7.3

K92.1

ICD-10 Finland

Melaena

1.8

7.3

535

J20

ICD-10 Finland

Acute bronchitis

1.6

7.3

165

1055

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

7.3

234

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

+∞

7.3

4291A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Myocardial degeneration

+∞

7.3

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

7.3

XFP02, ,

NOMESCO Finland

+∞

7.3

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

+∞

7.3

AQ2

Electrophysiological electroanatomical examination

+∞

7.3

4298B

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[SPORT HEART]

+∞

7.3

FXE00

NOMESCO Finland

Use of ECLA

+∞

7.3

5284

FHL

Mitral defect correction with flap prosthesis or graft

+∞

7.3

I30.8

ICD-10 Finland

Other forms of acute pericarditis

+∞

7.3

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

7.3

WX900

NOMESCO Finland

Resuscitation

10.9

7.3

Z49.2

ICD-10 Finland

Other dialysis

4.2

7.3

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.3

210

1421

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

7.3

191

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

7.2

402

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

7.2

129

777

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.4

7.2

210

N05BA02

ATC

chlordiazepoxide; systemic

2.3

7.2

229

M79.6

ICD-10 Finland

Pain in limb

1.3

7.2

719

5970

132

Kela drug reimbursment

Sarcoidosis

4.5

7.2

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.1

7.2

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.1

7.2

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

7.2

173

1125

A02BA04

ATC

nizatidine; systemic

1.6

7.1

142

881

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.2

7.1

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

7.1

125

750

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

7.9

7.1

R04.2

ICD-10 Finland

Haemoptysis

2.1

7.1

289

WX402

NOMESCO Finland

General anaesthesia

1.4

7.0

346

2590

ZXD00

NOMESCO Finland

Emergency procedure

2.2

7.0

251

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

7.0

104

595

C08CA02

ATC

felodipine; oral

1.6

7.0

152

964

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.9

7.0

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.2

7.0

265

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

6.9

422

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

6.9

240

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

13.8

6.9

C01BA03

ATC

disopyramide; systemic

13.8

6.9

J01FA09

ATC

clarithromycin; systemic

1.3

6.9

538

4320

J01FA15

ATC

telithromycin; oral

1.6

6.9

165

1071

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

6.9

746

6253

N03AE01

ATC

clonazepam; systemic

1.8

6.9

105

606

R4190

NOMESCO Finland

Nutritional therapy

2.1

6.9

320

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

6.8

SPAT1255

SPAT

Intravenous administration of medicine

1.7

6.8

108

630

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.8

6.8

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

6.8

281

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

6.8

282

2050

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

40.2

6.8

N05BA12

ATC

alprazolam; oral

1.6

6.7

175

1157

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

6.7

675

5599

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.2

6.7

C08CA07

ATC

nisoldipine; oral

3.2

6.7

R80

ICD-10 Finland

Isolated proteinuria

3.9

6.7

C08CA01

ATC

amlodipine; oral

1.3

6.7

651

5378

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

7.2

6.7

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

7.2

6.7

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

6.7

156

E05.89

ICD-10 Finland

Other thyrotoxicosis

22.6

6.7

G44.2

ICD-10 Finland

Tension-type headache

1.5

6.6

207

1424

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

6.6

181

R03AC12

ATC

salmeterol; inhalant

1.9

6.6

430

E87.6

ICD-10 Finland

Hypokalaemia

2.2

6.6

258

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.7

6.6

128

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

8.7

6.5

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.8

6.5

533

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.2

6.5

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.2

6.5

4140X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]

5.7

6.4

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.5

6.4

153

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

6.4

151

976

J01MA01

ATC

ofloxacin; systemic

1.6

6.4

152

984

5311

FHL

Bypass surgery in one vein

70.0

6.4

FFA10

NOMESCO Finland

Excision of lesion of atrium

70.0

6.4

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

6.4

507

W19

ICD-10 Finland

Unspecified fall

1.5

6.4

178

1196

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

6.4

220

1544

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.8

6.4

113

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.8

6.4

113

R03DA04

ATC

theophylline; systemic, rectal

1.7

6.4

109

650

C07AB03

ATC

atenolol; systemic

1.8

6.4

530

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.7

6.4

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.0

6.3

K65.0

ICD-10 Finland

Acute peritonitis

3.1

6.3

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

6.3

444

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.2

6.3

5CM18, ,

NOMESCO Finland

9.3

6.3

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

6.3

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

+∞

6.3

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

6.3

4241A

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]

+∞

6.3

4276A

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA SUPRAVENTRICULARIS]

+∞

6.3

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

+∞

6.3

Cardiac muscle biopsy

+∞

6.3

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

+∞

6.3

FE1AT

NOMESCO Finland

Pericardial puncture with ultrasound guidance

+∞

6.3

FPD10

NOMESCO Finland

Surgical ablation of atrial fibrillation

+∞

6.3

4229X

ICD-9 Finland

Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]

+∞

6.3

WX930

NOMESCO Finland

Thepapeutic hypothermia

+∞

6.3

AC2

MVR bio

+∞

6.3

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

+∞

6.3

I35.8

ICD-10 Finland

Other aortic valve disorders

26.7

6.2

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

26.7

6.2

FFC00

NOMESCO Finland

Suture of ostium secundum type ASD

26.7

6.2

NHQ40

NOMESCO Finland

Amputation of toe

3.0

6.2

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

6.2

126

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

6.2

139

889

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

6.2

109

656

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

6.2

411

TGC00

NOMESCO Finland

Bronchial lavation

2.3

6.2

181

N06AA12

ATC

doxepin; systemic

1.8

6.2

528

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

5.7

6.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

6.1

176

1191

RS220, ,

NOMESCO Finland

3.0

6.1

N07BB01

ATC

disulfiram; oral

1.8

6.1

456

A02BA02

ATC

ranitidine; systemic

1.4

6.1

337

2570

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

12.5

6.1

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

6.1

176

A07AA02

ATC

nystatin; oral

1.7

6.1

568

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

6.1

152

998

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

6.1

481

3865

GEA00

NOMESCO Finland

Mediastinoscopy

8.6

6.0

UJD02

NOMESCO Finland

Gastroscopy

1.8

6.0

450

WNF00

NOMESCO Finland

Infection source and contact determination

6.7

6.0

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

6.0

110

668

Single vessel balloon catheter extension

2.5

6.0

146

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.5

6.0

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1034

3187

4.89

313.22

5.9

1.8

1921.98

520.09

ng/l

10.31

916

2507

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

717

2650

3.41

151.66

8.2

2.7

774.51

541.52

ng/l

0.77

637

1937

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

405

1014

4.59

149.80

2.9

1.8

10.67

6.09

ug/l

1.92

349

861

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

372

898

4.70

143.79

4.9

1.8

305.54

87.41

ng/l

8.67

341

779

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

216

328

7.12

137.35

3.8

1.8

10.89

10.47

mg/l

0.31

204

302

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1091

5584

2.72

123.83

6.5

2.6

463.69

45.94

ng/l

0.96

851

3612

(3027456) Digoxin [Moles/volume] in Serum or Plasma

35.79

116.15

3.1

1.7

0.89

1.04

nmol/l

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1199

6673

2.56

111.35

26.0

5.6

1.39

1.10

inr

16.25

346

1883

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

184

321

6.11

101.77

6.5

2.8

0.34

0.33

u/ml

0.26

125

162

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

481

1788

3.10

96.46

3.9

2.2

21.87

24.57

3.67

421

1521

(3004789) Transferrin [Mass/volume] in Serum or Plasma

502

1919

3.03

95.79

3.9

2.1

2.23

2.33

g/l

3.76

465

1763

(3022948) Iron [Moles/volume] in Serum or Plasma

529

2084

2.96

95.63

3.8

2.2

12.19

14.05

umol/l

6.78

496

1932

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

250

607

4.47

94.61

3.5

1.7

35.64

40.93

u/l

3.41

223

546

(3020779) Urea [Moles/volume] in Serum or Plasma

361

1206

3.34

85.99

15.9

6.4

10.50

8.54

mmol/l

4.90

339

1151

(3012095) Magnesium [Moles/volume] in Serum or Plasma

537

2264

2.76

84.51

6.2

3.4

0.82

mmol/l

0.06

509

2121

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

531

2234

2.76

83.85

2.1

1.7

—

(3023368) Bacteria identified in Blood by Culture

802

4170

2.37

80.49

5.6

3.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

651

3307

2.32

67.04

3.0

1.6

1.14

1.17

mg/l

0.09

491

2480

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

146

302

5.08

66.78

1.6

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

477

2124

2.55

65.72

4.8

2.0

31.34

29.09

7.76

458

2062

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

138

288

5.02

62.44

1.6

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

369

1499

2.72

60.94

2.1

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

424

1885

2.51

58.05

11.7

5.4

1.11

1.02

mmol/l

7.29

394

1748

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

362

1492

2.67

57.93

2.0

1.6

—

(3000991) Gas panel - Venous blood

305

1163

2.85

56.65

13.6

7.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

110

209

5.46

55.29

1.6

1.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

785

4584

2.05

54.95

3.2

2.0

562.20

247.10

u/l

0.86

753

4300

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

369

1580

2.57

54.45

5.3

4.1

249.46

236.91

u/l

0.71

346

1484

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

138

327

4.41

53.40

1.8

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

154

397

4.07

53.32

1.8

1.5

1.16

1.20

g/l

0.69

145

374

(3003396) Base excess in Arterial blood by calculation

357

1533

2.55

52.24

11.1

7.0

1.41

0.86

mmol/l

1.68

287

1193

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

149

382

4.09

51.96

1.9

1.5

0.23

0.24

g/l

0.43

139

362

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

356

1534

2.54

51.69

11.0

7.0

5.13

5.11

kpa

0.07

334

1466

(3027801) Oxygen [Partial pressure] in Arterial blood

356

1535

2.54

51.62

11.0

7.0

12.03

12.82

kpa

1.68

334

1470

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

130

303

4.47

51.36

1.9

1.5

106.33

108.05

u/ml

0.05

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1215

8376

1.89

51.16

7.7

6.1

12.77

11.74

umol/l

1.26

1150

7937

(3013826) Glucose [Moles/volume] in Serum or Plasma

1335

9487

1.90

51.14

7.9

4.0

6.75

6.72

mmol/l

0.14

1285

8823

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

105

206

5.28

50.92

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

105

206

5.28

50.92

1.5

1.8

—

(3002032) Base excess in Venous blood by calculation

313

1296

2.62

49.23

6.5

3.5

1.74

1.83

mmol/l

0.17

275

1052

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1153

7897

1.87

48.77

11.7

5.8

1.20

1.22

mmol/l

7.12

1004

6706

(3013115) Eosinophils [#/volume] in Blood

1225

8557

1.86

48.62

9.6

6.0

0.20

e9/l

0.10

1084

7440

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

161

457

3.70

48.60

4.7

2.1

1870.58

398.64

ug/l

0.84

155

428

(3006315) Basophils [#/volume] in Blood

1191

8265

1.86

48.09

9.2

5.7

0.04

e9/l

0.09

1040

7105

(3001604) Monocytes [#/volume] in Blood

1187

8245

1.85

47.63

9.2

5.7

0.62

0.59

e9/l

4.47

1038

7085

(3019198) Lymphocytes [#/volume] in Blood

1218

8544

1.85

47.20

9.1

5.8

1.92

1.98

e9/l

0.27

1079

7508

(3021447) Carbon dioxide [Partial pressure] in Venous blood

309

1297

2.58

47.17

6.6

3.5

5.99

5.79

kpa

2.46

300

1257

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1053

7080

1.85

46.59

11.0

5.2

1.20

1.22

mmol/l

7.48

996

6400

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

125

310

4.19

45.54

6.6

5.5

735.88

764.14

iu/ml

0.02

(3016502) Oxygen saturation in Arterial blood

317

1369

2.51

45.52

11.9

7.5

96.01

96.14

0.20

302

1319

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

170

5.46

45.50

1.5

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

135

358

3.93

44.89

1.5

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

130

336

4.03

44.79

1.5

1.2

257.74

246.35

u/ml

0.14

199

(3014111) Lactate [Moles/volume] in Serum or Plasma

290

1219

2.56

44.01

12.4

6.4

1.23

1.37

mmol/l

1.81

284

1175

(3022096) Basophils/100 leukocytes in Blood

1088

7509

1.81

43.22

9.5

6.0

0.64

0.68

1.75

1044

6974

(3006504) Eosinophils/100 leukocytes in Blood

1116

7763

1.80

43.16

9.5

5.9

2.80

2.91

0.88

1072

7223

(3010375) cycloSPORINE [Mass/volume] in Blood

8.63

43.02

25.4

26.9

101.92

124.83

ug/l

1.35

(3019069) Monocytes/100 leukocytes in Blood

1120

7810

1.80

42.86

9.7

6.3

8.87

8.64

1.74

1077

7282

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

140

5.80

42.75

1.5

1.9

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

140

5.80

42.75

1.4

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

140

5.80

42.75

1.4

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

1147

8075

1.79

42.33

9.4

6.0

26.06

28.52

10.84

1100

7551

(3009445) Proteinase 3 Ab [Units/volume] in Serum

180

599

3.16

42.24

1.7

1.6

7.25

11.14

u/ml

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1111

7755

1.79

42.15

9.6

6.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

190

664

3.02

40.97

6.6

4.0

24.08

24.09

mmol/l

0.00

185

649

(3018010) Neutrophils/100 leukocytes in Blood

1128

7965

1.77

40.67

9.3

5.8

59.25

56.65

10.84

1076

7446

(3002173) Hemoglobin [Mass/volume] in Arterial blood

293

1285

2.45

40.49

12.1

7.8

122.88

124.41

g/l

0.57

285

1250

(3033658) Prothrombin time (PT) actual/Normal

681

4134

1.90

40.35

5.7

3.6

84.70

94.01

16.05

663

4042

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

168

560

3.15

39.28

2.1

1.9

1.86

2.48

ug/l

0.31

159

498

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

219

4.52

38.93

1.4

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

620

3695

1.91

38.62

2.9

2.0

2.99

2.83

mg/l

0.97

537

3089

(3024354) Oxygen [Partial pressure] in Venous blood

254

1068

2.54

38.34

5.5

3.1

4.92

4.59

kpa

1.64

242

1033

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

233

4.34

37.71

3.1

3.4

206.29

2458.76

u/ml

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

132

398

3.45

36.29

5.0

2.6

3.76

3.54

g/l

0.70

124

383

(3018418) pH of Serum or Plasma

725

4621

1.81

36.04

6.8

3.5

7.40

0.07

130

850

(3036489) Thrombin time

158

539

3.06

35.47

4.4

2.1

21.77

20.84

0.96

144

484

(3013650) Neutrophils [#/volume] in Blood by Automated count

1285

9641

1.70

35.47

12.5

9.2

4.43

4.09

e9/l

4.59

1129

8385

(3001122) Ferritin [Mass/volume] in Serum or Plasma

941

6499

1.73

35.20

4.3

2.5

153.68

145.18

ug/l

0.40

888

5983

(3037522) Nuclear Ab [Titer] in Serum

385

2012

2.08

34.56

1.5

1.3

451.71

530.23

titre

0.55

391

(3027945) Reticulocytes/100 erythrocytes in Blood

328

1617

2.19

34.22

3.2

2.5

1.76

1.68

0.69

295

1403

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

127

393

3.35

33.51

1.4

1.3

13.42

4.87

iu/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

158

565

2.92

32.61

1.5

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

161

588

2.86

31.97

1.9

1.7

1.54

1.53

g/l

0.02

135

504

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

234

1031

2.40

31.76

1.8

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

187

4.39

31.47

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

206

865

2.51

31.02

1.5

1.4

—

(40758558) Short blood count panel - Blood

641

4090

1.77

30.96

9.8

6.8

—

(3009343) pH of Capillary blood

214

921

2.45

30.56

5.0

3.3

7.42

0.12

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

179

708

2.65

30.48

15.6

8.8

24.46

24.16

mmol/l

0.57

170

690

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

215

933

2.43

30.14

5.0

3.3

5.18

5.10

kpa

0.59

205

877

(3036481) Cortisol [Moles/volume] in Serum or Plasma

281

1369

2.19

30.03

2.6

2.2

383.14

372.76

nmol/l

0.35

255

1261

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

165

4.53

29.96

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

207

891

2.44

29.53

5.0

3.3

1.75

1.34

mmol/l

0.66

163

632

(3019060) Gas panel - Arterial blood

198

847

2.45

28.61

6.0

5.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

110

5.28

28.16

1.4

1.3

—

(3042733) HLA Ab [Presence] in Serum

7.46

27.16

4.9

4.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

137

4.69

27.12

1.6

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

960

7006

1.61

27.04

6.8

4.6

34.48

35.97

g/l

10.67

887

6484

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

188

819

2.40

26.07

1.8

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

171

4.18

26.03

1.4

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

119

418

2.94

25.35

4.1

3.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

122

4.76

25.02

1.5

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

711

4893

1.64

25.02

4.1

3.0

43.27

102.66

e6/l

1.37

574

3742

(3024471) HLA-A [Type]

6.87

24.62

1.0

—

(3024932) HLA-DR beta [Type]

6.75

24.23

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

656

4455

1.65

24.20

4.1

3.0

0.47

0.43

e6/l

0.21

522

3352

(3042936) Bacteria identified in Isolate by Culture

370

2143

1.86

24.03

2.4

1.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

164

4.11

24.01

8.1

6.1

11.29

11.07

mg/l

0.13

150

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

118

426

2.86

23.92

1.3

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

227

3.52

22.67

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

183

837

2.28

22.66

9.1

7.0

24.69

24.47

mmol/l

0.31

174

794

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

118

440

2.77

22.52

1.5

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

754

5387

1.58

22.19

3.6

3.2

45.53

36.90

u/l

1.00

706

5106

(3020630) Protein [Mass/volume] in Serum or Plasma

226

1135

2.09

22.14

3.0

2.5

64.60

67.17

g/l

4.08

202

1031

(3023520) Reticulocytes [#/volume] in Blood

230

1171

2.06

21.71

3.0

2.5

73.61

66.93

e9/l

1.58

167

867

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

167

750

2.32

21.58

16.8

9.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

318

1815

1.86

21.50

2.7

2.8

8.61

8.77

umol/l

0.04

284

1603

(3018095) Leukocytes [#/volume] in Urine

785

5696

1.56

21.42

4.8

3.5

66.59

98.75

e6/l

1.02

605

4010

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

717

5106

1.57

21.21

3.3

2.5

59.15

59.88

u/l

0.09

674

4693

(3026782) Osmolality of Urine

497

3250

1.66

20.84

3.5

2.7

526.17

567.58

mosm/kgh2o

4.29

442

2768

(3047007) Chlamydophila sp Ab [Presence] in Serum

230

3.38

20.82

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

234

1217

2.02

20.82

2.1

2.5

10.59

g/l

0.01

214

1104

(3024928) Oxygen saturation in Venous blood

245

3.30

20.81

5.2

3.2

—

(3000850) Epithelial cells [#/volume] in Urine

508

3351

1.65

20.56

3.3

2.4

4.58

4.87

e6/l

0.33

473

2986

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

105

387

2.79

20.50

1.8

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

212

1073

2.07

20.31

6.8

3.6

123.13

77.49

ng/l

3.96

192

935

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

169

783

2.24

20.28

3.4

3.5

4.26

4.67

pmol/l

5.33

150

697

(3028626) Oxygen [Partial pressure] in Capillary blood

324

2.94

20.14

3.6

8.36

8.40

kpa

0.09

317

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

292

3.05

20.11

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

292

3.05

20.11

1.4

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

425

2693

1.70

20.01

3.3

2.7

1.40

1.15

e6/l

0.41

242

1499

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

408

2559

1.71

19.94

3.4

2.8

2.44

2.03

e6/l

0.50

225

1379

(3028026) IgM [Mass/volume] in Serum or Plasma

194

957

2.11

19.89

1.4

1.9

1.34

1.41

g/l

0.15

176

873

(3022313) Gas panel - Capillary blood

153

690

2.30

19.57

5.4

3.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

335

1999

1.78

19.49

2.0

1.6

—

(3013512) EKG study

634

4462

1.57

19.47

5.0

3.0

—

(36304419) Bacteria [Presence] in Urine

624

4376

1.57

19.46

4.0

2.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1546

13111

1.49

18.87

10.4

7.0

79.62

78.89

u/l

0.22

1478

12280

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

104

400

2.67

18.72

2.3

3.0

33.44

69.42

mg/l

1.09

333

(3034860) Kappa light chains.free [Mass/volume] in Serum

104

401

2.66

18.63

2.3

3.0

95.99

177.68

mg/l

0.25

334

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

102

390

2.68

18.58

2.3

3.0

3.16

1.94

ratio

—

(40760888) Immunoglobulin light chains.free panel - Serum

295

2.95

18.55

2.0

3.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.94

18.51

1.4

1.5

—

(3051651) Icteric interference index of Serum or Plasma

4.83

18.47

4.0

3.2

—

(3021589) Normoblasts [#/volume] in Blood

954

7398

1.47

18.22

15.1

8.4

0.00

e9/l

0.15

765

6032

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

170

3.59

18.20

2.3

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

454

2996

1.63

18.11

2.2

1.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

558

3870

1.57

18.07

2.9

2.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1297

10682

1.46

18.02

5.0

4.0

1554.41

1738.56

e6/l

0.05

161

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

162

3.64

17.97

1.1

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

141

637

2.29

17.97

2.1

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

303

1798

1.78

17.89

2.2

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

101

4.42

17.78

1.5

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

696

5084

1.52

17.75

3.0

2.3

—

(3021901) Oxygen saturation in Capillary blood

238

3.09

17.12

3.1

2.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

185

948

2.03

17.10

2.0

2.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

106

431

2.52

17.07

1.5

1.6

—

(3044889) 12 lead EKG panel

1398

11749

1.44

16.98

5.7

2.9

—

(40767503) Oxygen content in Capillary blood by calculation

276

2.89

16.47

2.9

2.2

16.13

17.00

1.01

137

(1616796) Gas panel - Central venous blood

289

2.83

16.26

4.5

2.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

366

2357

1.65

15.94

1.9

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

132

613

2.22

15.76

5.9

3.6

24.92

24.63

mmol/l

0.45

122

570

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

111

4.02

15.76

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

111

4.02

15.76

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

111

4.02

15.76

1.6

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

300

2.76

15.72

2.9

3.1

31.84

38.15

umol/l

1.13

280

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

129

596

2.23

15.60

1.9

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

4.19

15.56

1.4

1.2

1598.04

2593.38

e6/l

0.65

(3026493) Urate [Moles/volume] in Serum or Plasma

578

4172

1.50

15.24

3.7

2.4

1372.75

5173.80

umol/l

3.82

512

3693

(3020891) Body temperature

117

524

2.29

15.24

7.9

4.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

228

1304

1.82

15.15

1.5

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.32

15.00

1.3

1.2

71514.50

66266.21

e6/l

0.03

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

119

541

2.26

14.96

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

250

1479

1.77

14.83

2.4

2.3

0.21

0.22

g/l

1.26

230

1392

(3045788) Cell count panel - Pleural fluid

4.64

14.70

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

254

1519

1.75

14.51

2.9

2.5

40.56

69.93

u/l

0.45

221

1328

(3051611) Lipemic interference index of Serum or Plasma

142

3.50

14.42

3.9

2.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

414

2.40

14.11

1.4

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

107

3.88

14.04

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

107

3.88

14.04

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

107

3.88

14.04

1.3

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

250

2.81

13.99

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

103

456

2.31

13.80

2.5

2.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.51

13.77

1.5

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

4.51

13.77

1.5

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

305

2.61

13.66

2.5

2.0

125.91

132.98

g/l

1.42

205

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

110

3.77

13.52

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

110

3.77

13.52

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

110

3.77

13.52

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

4.21

13.42

1.4

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1352

11556

1.38

13.34

5.2

3.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.35

13.24

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

197

2.99

13.22

2.0

1.6

1.70

mmol/l

0.02

192

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.24

12.95

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

238

2.78

12.94

1.3

1.2

6.08

3.06

u/ml

0.36

101

(3004451) EKG impression Narrative

5.04

12.88

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

181

1019

1.84

12.64

1.4

1.3

45.51

56.36

au/ml

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

135

3.38

12.60

1.2

1.3

98.00

220.36

titre

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

193

1115

1.79

12.39

2.5

2.4

25.13

22.39

au/ml

0.11

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

206

1217

1.76

12.25

3.2

2.4

55.86

71.93

ml/min/173m2

4.82

472

(3026008) Bacteria identified in Urine by Culture

587

4409

1.44

12.25

3.4

3.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1442

12547

1.36

12.19

5.2

3.7

14.24

10.87

mm/h

10.90

1333

11568

(3024980) IgG subclass 4 [Mass/volume] in Serum

247

2.68

12.08

1.5

1.7

0.83

0.84

g/l

0.04

188

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

445

2.23

11.98

7.2

4.1

1.77

1.32

mg/l

3.40

415

(3007164) IgA [Mass/volume] in Serum or Plasma

439

3135

1.49

11.87

1.5

2.58

2.44

g/l

0.77

287

1965

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

292

2.51

11.74

1.6

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

145

3.14

11.26

1.4

1.2

7.69

6.76

g/l

0.78

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

926

7593

1.35

11.21

3.0

2.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

242

2.60

10.96

1.3

1.2

1.60

3.86

u/ml

1.01

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

159

2.99

10.84

2.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

354

2.30

10.80

1.2

1.1

5.07

2.16

u/ml

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

145

3.07

10.62

1.4

1.2

2.89

3.10

g/l

0.32

(4062490) Immunoglobulin typing, IgG

145

3.07

10.62

1.4

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

145

3.07

10.62

1.4

1.2

0.42

0.38

g/l

0.32

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

358

2.28

10.52

1.2

34.91

14.26

u/ml

0.61

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.81

10.48

1.2

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

152

3.00

10.42

3.5

4.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

302

2.36

10.03

1.3

1.1

—

9.22

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.68

9.97

1.2

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.06

9.95

1.7

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.06

9.95

1.7

2.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.16

9.89

1.2

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.16

9.89

1.2

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

267

2.43

9.88

1.2

1.1

10.76

35.71

u/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

267

2.43

9.88

1.0

1.1

—

(3034426) Prothrombin time (PT)

4.92

9.78

1.1

1.3

—

(3012501) Base excess in Blood by calculation

306

2.32

9.75

5.2

3.2

2.52

2.24

mmol/l

0.39

195

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

100

505

2.02

9.70

2.1

10.06

10.22

g/l

0.12

451

(3010421) pH of Blood

365

2.20

9.65

5.3

3.2

7.42

0.05

320

(3016650) Hepatitis A virus Ab [Presence] in Serum

269

2.38

9.26

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

102

529

1.97

9.20

1.6

4.49

0.20

iu/ml

0.46

(3020876) Protein [Mass/time] in 24 hour Urine

131

3.01

9.15

2.6

2.3

1.53

1.83

g/24h

0.19

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

103

537

1.96

9.15

2.1

7.40

7.33

g/l

0.14

484

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

103

537

1.96

9.15

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

103

537

1.96

9.15

2.1

3.78

3.72

g/l

0.17

484

(3003181) Sodium [Moles/volume] in Urine

228

2.49

9.13

1.3

55.11

66.71

mmol/l

1.27

182

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

223

2.50

9.05

1.3

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

456

2.03

9.04

1.1

1.3

51.67

86.44

titre

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

802

6605

1.32

8.90

2.8

2.2

74.93

76.18

nmol/l

0.59

726

5924

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

3.33

8.89

1.4

1.7

—

(4035726) Immunohistochemistry procedure

217

1416

1.58

8.81

1.7

1.3

—

(40768806) Pleura Pathology biopsy report

3.26

8.62

1.3

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

4.57

8.58

1.1

1.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

514

1.94

8.58

1.2

0.17

1.14

u/ml

1.33

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

248

2.37

8.53

1.8

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

166

2.68

8.39

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

214

2.46

8.32

1.1

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

251

2.34

8.31

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

191

2.54

8.24

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

240

1627

1.53

8.22

4.1

2.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

395

2960

1.40

8.02

1.9

1.7

1156.78

1129.75

nmol/l

0.23

312

2248

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

116

658

1.80

7.98

8.8

1.4

2.41

4.73

mg/l

1.63

110

466

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

314

2.16

7.96

1.4

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

157

2.64

7.62

8.7

6.3

6.17

7.65

mmol/l

3.01

129

(3017181) Myelocytes/100 leukocytes in Blood

203

1353

1.55

7.52

4.8

4.1

1.02

0.90

0.32

100

462

(40761535) Cells panel - Urine sediment

197

1305

1.55

7.50

4.2

3.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

473

3686

1.35

7.50

4.3

3.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

215

2.35

7.31

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

3.62

7.29

2.2

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

100

559

1.82

7.25

5.6

5.5

1.97

1.62

0.42

526

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

347

2.05

7.23

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

553

1.82

7.19

6.2

5.6

0.94

0.90

0.45

520

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.57

6.86

1.1

183.34

237.17

iu/ml

0.43

(3011412) CD3 cells [#/volume] in Blood

148

2.59

6.86

2.3

2.7

1.03

1.28

e9/l

0.84

129

(3035880) pH of Pleural fluid

4.11

6.81

1.3

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.27

6.74

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

115

2.81

6.74

2.4

2.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

152

973

1.60

6.73

1.3

319.88

264.27

u/ml

0.28

140

893

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

309

2.07

6.72

2.3

3.7

58.87

56.14

1.16

309

(3010813) Leukocytes [#/volume] in Blood

1926

20278

0.76

6.65

34.9

16.9

7.21

6.69

e9/l

9.92

1879

19569

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.72

6.63

1.6

2.0

257.40

808.14

u/ml

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

181

2.40

6.62

1.7

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.02

6.62

1.2

1.7

—

(3047181) Lactate [Moles/volume] in Blood

437

1.88

6.59

7.2

6.5

1.38

1.32

mmol/l

0.25

381

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

12.27

6.58

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1927

20280

0.76

6.55

35.2

17.0

134.64

138.33

g/l

19.48

1904

19913

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

342

2585

1.38

6.54

1.3

1.2

53.24

32.29

iu/ml

0.74

101

824

(3026361) Erythrocytes [#/volume] in Blood

1927

20274

0.77

6.48

34.9

16.9

4.48

4.58

e12/l

13.52

1874

19571

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

101

2.89

6.47

2.1

2.2

—

(3024731) MCV [Entitic volume]

1927

20273

0.77

6.47

34.8

16.8

91.09

90.72

2.78

1902

19906

(3035941) MCH [Entitic mass]

1927

20271

0.77

6.44

34.7

16.8

30.32

30.35

0.32

1902

19902

(3024891) Influenza virus A+B Ag [Presence] in Specimen

434

1.87

6.41

1.3

1.1

—

(3025941) Bacteria identified in Stool by Culture

141

898

1.60

6.39

1.4

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

302

2.05

6.36

2.1

3.5

4.46

3.96

e9/l

0.96

302

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.75

6.36

2.1

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.75

6.36

2.0

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.75

6.36

2.0

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.81

6.34

2.2

2.1

3.22

2.92

g/l

1.51

449

(3015736) pH of Urine

780

6626

1.26

6.32

4.0

3.0

5.87

5.80

0.23

528

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1381

12500

1.24

6.28

4.2

3.5

14.89

14.73

pmol/l

1.47

1278

11236

(3009542) Hematocrit [Volume Fraction] of Blood

1926

20247

0.77

6.26

35.8

17.0

40.18

41.03

2.64

1835

18890

(3007461) Platelets [#/volume] in Blood

1927

20255

0.77

6.24

34.9

16.9

249.27

249.01

e9/l

0.06

1885

19619

(3015377) Calcium [Moles/volume] in Serum or Plasma

657

5476

1.27

6.23

4.5

3.3

2.33

2.36

mmol/l

4.24

569

4816

(3035350) Ketones [Presence] in Urine by Test strip

938

8147

1.24

6.23

4.3

3.3

0.00

estimate

1.34

181

1608

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1681

17958

0.79

6.21

5.2

4.5

2.62

2.82

mmol/l

16.22

1569

16524

(3022145) Colonoscopy Study observation

255

1850

1.42

6.20

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

528

1.77

6.16

3.6

0.46

0.36

g/l

0.33

243

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

163

2.41

6.12

1.7

1.3

—

nmol/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

342

1.95

6.08

1.3

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

406

1.87

6.07

1.7

1.4

—

(3011648) Oxygen content in Venous blood

105

2.78

6.05

4.2

3.8

11.50

11.21

0.14

105

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.60

6.03

2.5

2.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

776

6618

1.25

6.01

2.1

1.9

92.91

94.97

pmol/l

0.60

423

3483

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

379

1.90

6.00

2.1

2.3

0.01

0.00

g/l

0.49

353

(3037756) Immunofixation for Serum or Plasma

276

2.05

5.93

1.4

1.6

—

(3028433) Virus identified in Specimen by Culture

3.69

5.92

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

403

1.86

5.89

2.1

2.2

0.02

0.04

g/l

0.46

375

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.13

5.89

1.7

3.6

106.25

127.76

umol/l

0.21

(3021960) Folate [Moles/volume] in Serum or Plasma

450

3600

1.31

5.83

1.7

1.5

19.07

20.31

nmol/l

1.02

390

3057

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

427

1.83

5.79

2.1

37.28

38.38

g/l

0.76

374

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

206

2.21

5.76

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.92

5.71

5.2

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

220

2.16

5.70

1.7

1.6

—

(3019977) pH of Arterial blood

3.04

5.64

4.8

3.0

7.44

7.42

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.89

5.62

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

178

1230

1.48

5.61

4.7

4.0

0.60

0.66

0.19

391

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

374

1.87

5.59

2.2

2.3

0.00

g/l

-0.00

352

(3009261) Glucose [Presence] in Urine by Test strip

940

8237

1.23

5.58

4.3

3.3

0.00

estimate

0.80

165

1451

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

462

1.78

5.57

2.2

0.38

1.13

g/l

1.62

403

(3000494) Fungus identified in Specimen by Culture

255

1887

1.39

5.54

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.78

5.46

1.8

1.4

5.10

7.32

u/l

0.29

(3035637) Corticotropin [Mass/volume] in Plasma

185

2.24

5.45

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

160

2.33

5.42

1.0

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

927

8130

1.23

5.41

5.9

4.5

0.00

estimate

0.50

179

1518

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

16.05

5.41

1.4

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

136

2.45

5.37

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

5.62

5.37

7.6

5.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.56

5.32

1.2

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

272

2048

1.37

5.32

2.7

2.5

234.17

147.43

ug/g

2.06

219

1648

(3039000) Anion gap in Blood

304

1.93

5.22

8.8

8.0

11.77

11.34

mmol/l

0.29

272

(3018572) Chloride [Moles/volume] in Blood

304

1.93

5.22

8.8

8.0

103.75

105.51

mmol/l

1.28

272

(3038071) Oxygen [Partial pressure] in Mixed venous blood

5.93

5.21

7.7

5.7

—

(1761868) Lipid panel - Serum or Plasma

558

6616

0.80

5.17

3.1

2.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.86

5.11

4.3

5.0

—

(3044927) Protein electrophoresis panel - Urine

146

2.35

5.08

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

204

2.13

5.08

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

438

3552

1.28

5.08

1.3

1.2

2.29

1.61

u/ml

0.45

933

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.21

5.07

1.8

—

(40768797) Stomach Pathology biopsy report

288

2207

1.35

5.03

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

205

2.12

5.02

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

147

2.33

5.01

1.1

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1643

17465

0.82

4.97

4.8

4.0

1.35

1.42

mmol/l

10.62

1530

16083

(3008295) Osmolality of Serum or Plasma

161

2.25

4.91

1.3

1.5

285.23

283.26

mosm/kgh2o

0.11

123

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.13

4.91

1.2

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

181

1289

1.44

4.90

5.1

4.1

0.07

0.11

0.53

400

(3000012) Reticulocyte production index

181

2.17

4.87

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1659

17607

0.82

4.87

4.8

4.1

4.42

4.69

mmol/l

22.16

1554

16304

(3042631) Mycobacterium sp identified in Specimen

201

2.11

4.86

2.0

2.8

—

(3021788) Differential panel - Synovial fluid

264

1.95

4.78

1.8

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

251

1.97

4.74

1.1

1.3

14.28

41.52

u/l

1.62

208

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

204

2.08

4.69

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

204

2.08

4.69

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

206

2.06

4.58

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

3.42

4.46

6.9

4.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

124

1797

0.67

4.45

1.7

—

(3000492) Spirometry study

230

1740

1.35

4.38

1.5

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.66

4.36

1.2

2.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.66

4.36

1.2

1.0

86.88

88.57

—

(3044941) Cell count panel - Synovial fluid

246

1.93

4.30

1.6

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

126

2.32

4.26

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.75

4.18

1.7

2.9

—

(3023419) Bacteria identified in Sputum by Culture

209

1.98

4.06

2.0

2.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.63

4.05

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

10.02

4.01

1.9

3.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

503

5893

0.82

4.00

3.5

4.1

22.30

21.69

0.33

205

2793

(3017704) Immunofixation for Urine

2.64

3.89

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

7.29

3.86

1.1

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

113

2.31

3.85

2.6

2.9

458.10

629.61

e6/l

0.82

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.30

3.81

1.2

1.1

87.71

79.29

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.54

3.79

1.0

1.1

—

(3014891) Appearance of Pleural fluid

8.77

3.77

1.4

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

8.77

3.77

1.0

17.57

5.75

u/l

—

(3045142) Bone marrow Pathology biopsy report

160

2.08

3.76

1.2

1.4

—

(3025159) Blasts/100 leukocytes in Blood

166

1223

1.38

3.76

5.0

4.1

0.00

0.08

2.51

325

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

12.02

3.76

8.2

4.2

—

(3047189) Immunofixation for 24 hour Urine

2.80

3.68

1.1

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

357

4299

0.80

3.66

2.7

2.9

0.78

ug/l

0.00

224

2746

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.12

3.64

6.4

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.12

3.64

6.4

2.3

—

(3019225) pH of Specimen

213

1641

1.33

3.62

6.5

3.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

110

2.29

3.61

2.6

3.0

0.23

0.22

e9/l

0.08

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

483

1.59

3.61

1.3

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.73

3.59

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.73

3.59

1.2

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

352

1.69

3.59

1.9

1.8

3.07

5.32

iu/l

2.08

132

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1851

17654

1.20

3.58

25.5

11.4

25.36

25.08

mg/l

0.14

1616

13504

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.66

3.56

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

111

2.26

3.54

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1203

0.65

3.50

1.3

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

3.88

3.48

2.0

2.1

1.18

mmol/l

0.05

(3044242) Glucose [Moles/volume] in Arterial blood

2.62

3.47

1.5

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

489

1.57

3.44

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

194

1.92

3.43

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

170

1278

1.35

3.42

6.8

3.5

1.22

1.23

mmol/l

1.37

157

1093

(3003327) Ova and parasites identified in Stool by Light microscopy

530

1.55

3.41

1.9

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

2.99

3.41

2.2

2.4

294.29

137.89

e6/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

161

2.00

3.34

1.8

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.73

3.34

4.1

6.5

4.64

6.38

mmol/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

189

1.92

3.34

2.2

1.8

29.14

20.99

mg/l

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

485

1.56

3.34

1.3

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

182

1.94

3.33

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

360

1.65

3.32

2.2

1.7

15800.86

13713.99

e6/l

0.22

254

(3020191) Ethanol [Moles/volume] in Serum or Plasma

148

2.04

3.30

1.6

1.5

1.16

1.28

promille

0.18

120

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.42

3.30

1.2

1.12

1.06

ratio

—

(3026480) Teichoate Ab [Titer] in Serum

8.59

3.26

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.03

3.25

1.2

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.75

3.23

1.2

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

228

1.81

3.20

7.4

2.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

110

2.19

3.18

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

130

2.09

3.18

3.1

2.9

—

(21494434) Karyotype in Bone marrow

111

2.17

3.12

1.1

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

118

2.13

3.10

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

118

2.13

3.10

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

253

1.75

3.09

1.6

1.9

4.47

5.14

mmol/24h

0.69

219

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.01

3.08

1.1

90.90

95.80

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

125

2.09

3.08

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.51

3.05

1.0

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

7.51

3.05

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

7.51

3.05

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.01

3.05

3.6

2.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.51

3.04

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

106

2.18

3.02

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

648

7264

0.85

3.02

3.8

4.7

1.86

3.36

ug/l

1.97

575

6586

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.30

2.99

1.1

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1604

16830

0.86

2.98

4.4

3.6

1.38

1.33

mmol/l

1.57

1490

15379

(3009871) Measles virus Ab [Titer] in Serum

2.60

2.87

1.3

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

2.51

2.87

2.4

1.6

189.25

143.53

1.01

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1638

15577

1.16

2.84

5.0

4.1

1.98

2.06

mu/l

0.23

1521

14134

(3019832) Treponema pallidum Ab [Presence] in Serum

180

1408

1.30

2.80

2.1

1.7

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.45

2.79

1.3

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.65

2.79

1.5

1.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

8.34

2.75

1.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.34

2.75

6.4

7.0

620.20

558.17

umol/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

5.01

2.72

2.0

4.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.24

2.72

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.46

2.69

1.6

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

294

2453

1.23

2.66

1.2

8.48

12.64

u/ml

0.53

101

982

(40757373) Influenza virus identified in Isolate

3.15

2.64

1.4

1.9

—

(3038026) Centromere Ab [Units/volume] in Serum

120

2.01

2.60

1.3

1.1

—

70.97

—

(3024263) Appearance of Synovial fluid

2.26

2.60

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.34

2.60

2.1

2.2

1.19

mmol/l

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

177

1.82

2.59

1.7

1.5

55.30

55.38

0.00

117

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

249

2048

1.24

2.58

11.2

5.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.61

2.57

1.1

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.01

2.56

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.46

2.54

1.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.61

2.53

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.51

2.53

1.1

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

373

1.54

2.49

2.9

2.0

0.93

0.77

nmol/l

0.85

318

(3029937) Albumin [Presence] in Urine by Test strip

493

4340

1.17

2.47

4.7

3.6

0.01

0.00

estimate

0.29

163

1458

(3000570) Elastase.pancreatic [Mass/mass] in Stool

455

1.49

2.46

1.4

263.26

285.95

ug/g

0.47

259

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

174

1.79

2.42

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.26

2.37

1.4

2.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

146

1.86

2.37

1.1

1.3

2.20

1.95

mmol/l

0.47

139

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.26

2.34

2.7

4.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.83

2.34

1.6

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.83

2.34

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

2.23

2.27

3.1

2.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.56

2.27

1.0

—

(3049717) Cytology report of Urine Cyto stain

641

1.39

2.25

2.0

2.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.90

2.25

1.9

1.5

253.29

105.06

ng/l

—

(3044290) Cell count panel - Cerebral spinal fluid

359

1.52

2.22

2.1

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.56

2.21

1.0

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.20

2.21

3.0

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

287

2436

1.20

2.20

1.9

1.8

1.56

1.47

1.13

249

2187

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

343

2962

1.18

2.17

3.8

3.0

2.45

mmol/l

0.25

282

2605

(3009214) Lutropin [Units/volume] in Serum or Plasma

519

1.42

2.16

1.3

1.5

8.26

7.45

u/l

0.24

435

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

397

1.47

2.10

1.9

1.3

3.74

3.77

mmol/l

0.08

378

(3005011) Chlamydia sp Ab [Titer] in Serum

3.21

2.09

1.4

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1642

17050

0.89

2.08

4.8

4.2

6.02

5.93

mmol/l

1.39

1500

15485

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.56

2.07

1.0

1.2

—

(3033799) Differential panel - Peritoneal fluid

2.71

2.07

1.7

2.0

—

(21494755) Public health laboratory ask at order entry panel

160

1970

0.80

2.04

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.01

2.04

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

125

977

1.29

2.03

1.2

111.97

136.80

iu/ml

0.28

358

(3036071) Salmonella sp Ab [Titer] in Serum

2.15

1.98

1.1

—

(36660697) Celiac disease serology panel - Serum

155

1251

1.25

1.95

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.03

1.95

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.98

1.95

1.0

1.1

10.64

5.58

iu/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

696

6375

1.13

1.94

4.4

3.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

149

1.75

1.94

1.7

1.5

25.45

29.92

0.24

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

599

1.36

1.93

1.1

—

0.85

—

(3009508) Creatinine [Moles/volume] in Urine

586

5312

1.14

1.93

3.9

3.2

7.21

8.22

mmol/l

6.19

516

4504

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.12

1.92

1.4

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.12

1.92

1.4

2.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1881

18235

1.14

1.91

29.2

12.6

139.37

139.68

mmol/l

6.31

1840

17677

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.01

1.90

1.9

2.0

—

(3036180) Methadone [Presence] in Urine

1.96

1.90

1.4

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1258

11934

1.11

1.85

3.8

2.9

63.38

48.33

u/l

4.99

1182

11123

(3023323) Follitropin [Units/volume] in Serum or Plasma

604

1.35

1.85

1.2

1.4

32.06

24.12

iu/l

1.02

507

(40768800) Prostate Pathology biopsy report

466

0.62

1.84

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

190

1.64

1.84

4.9

3.4

—

(3028707) Methadone [Presence] in Urine by Screen method

360

1.45

1.81

3.2

2.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.35

1.77

1.3

1.1

—

(3017732) Neutrophils [#/volume] in Blood

145

1178

1.25

1.75

3.4

3.1

5.93

5.74

e9/l

0.04

121

951

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.67

1.72

1.3

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.85

1.71

2.2

4.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.14

1.71

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1870

19196

0.89

1.70

14.6

9.2

31.28

28.14

u/l

1.80

1812

18438

(3023410) Appearance of Cerebral spinal fluid

179

1.63

1.69

3.0

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

391

1.42

1.69

2.3

1.5

3207.64

966.98

e6/l

0.71

324

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

391

1.42

1.69

2.3

1.4

42.69

21.53

e6/l

0.27

313

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

451

1.38

1.67

1.9

1.3

490.45

544.23

mg/l

0.49

428

(4200892) Spirometry reversibility

136

1107

1.24

1.63

1.5

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.58

1.61

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.84

1.61

2.0

2.8

44.18

41.88

0.23

(3023103) Potassium [Moles/volume] in Serum or Plasma

1882

18307

1.12

1.59

29.6

12.6

3.99

3.97

mmol/l

2.16

1842

17707

(3002079) Sodium [Moles/time] in 24 hour Urine

2.07

1.59

1.0

1.3

144.77

183.92

mmol/24h

0.96

(3016244) Insulin [Units/volume] in Serum or Plasma

1.91

1.59

7.0

3.1

29.78

21.77

mu/l

0.33

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.70

1.58

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.70

1.58

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.70

1.58

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.85

1.55

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

210

1795

1.19

1.55

2.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

298

1.45

1.53

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

108

1.76

1.50

2.3

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

108

1.76

1.50

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.16

1.50

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

300

1.44

1.49

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

186

1.57

1.48

2.5

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

395

1.37

1.44

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.13

1.44

8.6

6.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.25

1.40

1.2

1.3

—

(3027944) Amphetamines [Presence] in Urine

108

876

1.24

1.38

3.1

2.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.94

1.38

2.3

1.6

—

922607.14

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.20

1.37

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.20

1.37

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.20

1.37

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.20

1.37

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

486

1.32

1.36

1.2

1.3

243.26

218.49

miu/ml

0.14

221

(3000764) Benzodiazepines [Presence] in Urine

109

887

1.24

1.36

3.0

2.1

—

(3000330) Specific gravity of Urine by Test strip

761

1.26

1.36

4.9

3.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.83

1.35

1.3

2.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.76

1.34

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

500

0.70

1.34

1.9

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.85

1.29

1.4

1.3

5.62

4.56

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.36

1.29

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.78

1.28

1.2

2.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.09

1.27

1.3

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.94

1.27

1.3

1.1

1242.25

1618.15

miu/ml

0.81

(3027008) Opiates [Presence] in Urine

109

895

1.23

1.27

2.9

2.1

—

(3044007) Cell count panel - Peritoneal fluid

2.29

1.26

1.8

2.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.29

1.26

1.1

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.40

1.24

1.2

1.4

26.80

26.58

g/l

—

(3035933) Granulocytes/100 leukocytes in Blood

2.23

1.24

1.1

1.4

—

(3028300) Cannabinoids [Presence] in Urine

109

898

1.22

1.23

3.0

2.1

—

(3017569) Oxygen content in Arterial blood

1.91

1.22

1.8

2.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

548

5076

1.10

1.22

4.7

3.8

20.22

6.75

mg/mmol

4.26

365

3263

(1001926) Buprenorphine [Presence] in Urine by Screen method

691

1.25

1.22

3.3

2.1

—

(3004775) Volume in Urine collected for unspecified duration

132

1.60

1.20

2.6

2.0

759.38

626.64

0.49

(3051387) C reactive protein [Mass/volume] in Capillary blood

395

0.68

1.20

5.5

3.1

25.19

26.63

mg/l

0.09

227

(3010144) Erythrocytes [#/volume] in Synovial fluid

148

1.56

1.20

2.1

1.2

9443.75

87309.25

e6/l

1.02

(3016879) Cocaine [Presence] in Urine

101

829

1.23

1.19

3.0

2.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.31

1.18

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

382

0.68

1.18

1.1

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

161

1863

0.85

1.16

1.3

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

403

1.32

1.16

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

447

1.30

1.15

1.1

1.0

1.87

4.08

u/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.15

1.0

2.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.15

1.8

2.6

0.80

0.30

u/field

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.50

1.15

1.4

1.6

—

(40761536) Microorganisms panel - Urine sediment

160

1377

1.17

1.15

4.7

3.5

—

(3019150) Specific gravity of Urine by Refractometry

396

3625

1.11

1.12

4.9

3.5

1.02

kg/l

0.73

526

(3003694) ABO and Rh group [Type] in Blood

508

4709

1.10

1.12

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.00

1.12

1.8

1.6

2028.38

77.42

nmol/24h

—

(40768795) Lymph node Pathology biopsy report

136

1.55

1.08

1.1

1.2

—

(3012516) Albumin [Mass/volume] in Urine

518

4817

1.10

1.07

4.1

3.2

460.46

344.59

mg/l

0.23

352

3101

(3045414) Leukocytes [Presence] in Urine

668

1.24

1.06

2.4

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

106

887

1.20

1.06

2.6

2.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

413

4471

0.91

1.04

1.6

1.59

1.40

mmol/l

1.96

351

3801

(40765096) Chromosome analysis panel by Banding

1.96

1.03

1.0

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.96

1.03

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.27

1.03

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.27

1.03

1.2

1.0

—

(3017509) Phencyclidine [Presence] in Urine

2.27

1.03

1.2

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

220

1958

1.14

1.02

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

100

838

1.20

1.00

1.4

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

131

1.53

0.99

3.5

5.5

99.32

42.18

u/ml

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.18

0.98

1.0

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.95

0.97

1.4

2.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.85

0.96

2.9

3.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

187

1655

1.14

0.96

3.7

4.4

12.74

24.29

ug/l

0.83

149

1369

(3003888) Timothy IgE Ab [Units/volume] in Serum

294

1.33

0.94

1.2

1.1

9.45

6.72

u/ml

0.45

159

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.73

0.92

1.3

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.14

0.91

1.0

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.67

0.91

1.3

1.2

—

(3045424) Erythrocytes [Presence] in Urine

287

1.33

0.91

1.3

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

102

1.57

0.90

1.6

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

100

848

1.19

0.90

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

297

1.32

0.89

1.9

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

325

2988

1.10

0.87

1.8

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.00

0.87

1.3

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

281

1.32

0.86

1.1

1.26

2.34

u/ml

0.80

144

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

104

1.54

0.84

2.4

2.8

42163.75

41842.75

ug/l

0.02

104

(40761511) CBC panel - Blood by Automated count

1830

18622

0.93

0.84

21.5

10.7

—

(3006653) Thiamine [Moles/volume] in Blood

1.61

0.81

1.4

1.3

141.05

140.41

nmol/l

0.02

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

391

1.26

0.81

2.7

2.1

271.99

94.28

ug/min

0.94

233

(1761482) Bacteria [#/volume] in Urine by Culture

427

1.25

0.81

4.8

4.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

130

1.46

0.80

1.7

1.4

81.32

82.81

umol/l

0.06

130

(3011288) Drugs identified in Urine by Screen method

583

1.21

0.79

6.1

2.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

277

1.30

0.78

1.8

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.59

0.78

2.6

2.1

40.20

100.16

ug/min

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.70

0.75

1.3

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

244

1.32

0.75

1.1

1.0

2.46

2.27

u/ml

0.07

120

(40768804) Tissue Pathology biopsy report

702

6701

1.07

0.75

2.3

2.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.74

1.3

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

193

1.35

0.73

1.1

1.0

0.07

0.52

u/ml

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.00

0.72

1.0

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

186

1.35

0.70

4.0

1.8

—

(1002224) Polysomnography panel

760

1.16

0.68

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.85

0.68

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

558

1.19

0.66

1.8

1.6

328.51

287.87

mu/l

0.26

510

(3008401) Mugwort IgE Ab [Units/volume] in Serum

285

1.27

0.66

1.2

1.1

1.45

1.53

u/ml

0.03

130

(3052592) Norovirus Ag [Presence] in Stool

1.79

0.66

1.0

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1155

11229

1.05

0.64

3.3

2.9

—

(3002619) Bacteria identified in Specimen by Culture

1.67

0.61

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

194

1777

1.10

0.61

1.5

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

113

1.42

0.61

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

1556

15262

1.05

0.60

28.8

14.0

14.56

14.93

0.62

1532

14951

(3003338) MCHC [Mass/volume]

1529

15572

0.95

0.59

30.8

14.7

331.97

333.85

g/l

11.60

1515

15421

(3048879) Bone marrow aspiration report

1.72

0.57

1.3

2.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

372

3513

1.07

0.57

1.7

1.6

65894472.05

37882289.45

pmol/l

0.23

302

2946

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

115

1.39

0.56

1.3

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.62

0.55

1.0

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

477

4545

1.06

0.55

3.9

3.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

148

0.67

0.55

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

177

1.30

0.54

1.5

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.47

0.54

1.3

310.92

508.68

u/l

0.61

(3038177) Helicobacter pylori Ab [Presence] in Serum

276

1.23

0.54

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.52

0.52

1.2

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

143

1.33

0.52

1.2

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.62

0.52

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

234

1.24

0.49

1.1

1.0

5.03

4.13

u/ml

0.13

112

(44816559) Phosphatidylethanol [Mass/volume] in Blood

355

1.19

0.47

1.4

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

191

1.26

0.46

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.45

0.44

1.5

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

437

0.84

0.44

1.4

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

220

1.23

0.43

1.1

2.24

6.11

u/ml

1.37

(3022621) pH of Urine by Test strip

110

1003

1.10

0.42

3.8

2.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.38

0.42

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.52

0.41

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

105

0.67

0.39

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.34

0.38

1.3

1.8

1.69

2.10

umol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

686

1.11

0.37

1.7

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

850

1.10

0.36

1.4

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.66

0.35

1.0

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1692

16724

1.04

0.35

22.3

10.7

81.65

83.87

ml/min/173m2

2.96

1445

13473

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.33

0.35

4.8

7.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

179

0.78

0.35

1.9

1.7

—

(40768443) Skin Pathology biopsy report

661

1.11

0.34

1.1

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

178

0.79

0.34

1.4

1.5

—

(3005570) Glucose [Moles/volume] in Urine

145

1.24

0.33

1.4

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

293

1.16

0.33

6.6

5.2

351.56

358.64

umol/l

0.09

256

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

177

0.79

0.33

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

827

1.09

0.32

2.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

333

1.14

0.31

1.2

1.1

1.79

2.43

u/ml

0.22

177

(3025577) Chromium [Mass/volume] in Blood

0.73

0.31

2.1

1.9

1.89

2.05

ug/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.32

0.30

1.1

1.5

8.58

8.70

ug/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

100

0.70

0.30

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

184

1.20

0.30

1.4

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

109

0.73

0.29

1.5

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

708

1.09

0.28

2.8

2.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

114

1066

1.07

0.28

1.2

1.3

—

(4146454) Self-monitoring of blood glucose

173

0.81

0.28

3.2

2.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.32

0.28

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

606

1.09

0.26

4.7

3.6

119.62

3791.42

u/ml

1.17

525

(3005033) Fetal Nuchal fold Thickness US

203

0.84

0.26

1.2

1.4

—

(40768441) Liver Pathology biopsy report

123

1.22

0.25

1.1

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

105

1.24

0.24

2.8

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

180

1879

0.95

0.23

2.4

2.2

13.65

13.64

nmol/l

0.01

164

1703

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

210

0.86

0.22

1.4

153.88

222.33

pmol/l

0.83

210

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.22

0.22

2.8

2.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.19

0.21

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.25

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

0.17

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.3

—

1.45

—

(44813793) Dust mix specific IgE antibody measurement

104

0.77

0.21

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.24

0.20

1.1

1.3

—

77.50

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

134

0.82

0.20

1.0

776.33

664.20

ng/l

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.20

0.0

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

208

0.86

0.20

1.2

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

302

0.89

0.19

1.6

1.4

—

(40768793) Breast Pathology biopsy report

298

1.11

0.19

1.4

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.21

0.18

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

268

0.89

0.17

1.4

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1603

16132

0.98

0.17

6.1

5.2

39.75

39.48

mmol/mol

0.54

1503

14914

(3047352) Trisomy 18 risk [Likelihood] in Fetus

204

0.88

0.16

1.2

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.77

0.15

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

588

1.06

0.13

1.6

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

108

0.83

0.13

1.7

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

251

0.92

0.12

1.3

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

198

0.91

0.10

1.3

—

(3022689) Creatine [Moles/volume] in Urine

1.11

0.09

1.6

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.06

0.09

1.2

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

145

1.10

0.09

1.1

2.6

5.52

6.47

umol/l

—

102

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.79

0.08

2.8

2.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

358

0.95

0.08

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

362

1.05

0.07

3.8

2.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.02

0.07

4.0

2.2

143.89

153.72

nmol/l

—

(3015183) Erythrocyte sedimentation rate

100

1.10

0.05

1.4

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

140

0.93

0.04

1.5

2.1

3.87

1.94

u/field

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

407

1.03

0.04

2.7

2.4

3708.67

2281.26

u/l

0.19

145

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

251

0.96

0.04

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

251

0.96

0.04

1.3

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

172

1701

1.01

0.04

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

250

0.96

0.03

1.3

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

289

0.97

0.02

1.2

1.1

1.20

1856.65

iu/ml

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

152

1.05

0.02

8.8

14.6

813.63

802.53

nmol/l

0.03

146

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

137

0.95

0.01

1.5

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

109

1.01

0.00

1.1

1.4

1.50

1.51

g/l

0.04

109

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

149

1.01

0.00

1.1

1.5

—

(3008898) HLA-B27 [Presence]

595

1.01

0.00

1.1

—

(4034850) Laboratory test

560

1.00

0.00

17.9

7.9

—

(3002256) Pathology report gross observation

220

2203

1.00

0.00

1.5

1.3

—

(4281824) Cell count and differential, peritoneal fluid

139

1.01

0.00

1.4

1.1

—

(3025130) Human papilloma virus identified in Specimen

146

1.03

0.00

1.7

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

193

0.98

0.00

1.5

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

208

2074

1.00

0.00

4.2

31.09

31.64

0.33

160

1368

(3045683) HLA typing for celiac disease panel - Blood or Tissue

108

1.02

0.00

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

170.33

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.91

-0.00

6.0

6.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

0.91

-0.00

2.8

3.9

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

0.04

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.35

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3045716) Anion gap in Serum or Plasma

0.88

-0.00

1.3

1.8

8.82

9.86

mmol/l

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.91

-0.00

3.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.2

—

8.26

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_OTHILLHEART and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_OTHILLHEART	2.38 [2.04, 2.77]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.038

During the follow-up period (1.1.1998 — 31.12.2019), 1023 out of 3349 females with I9_OTHILLHEART died.

Males

Parameter	HR [95% CI]	p-value
I9_OTHILLHEART	2.371 [2.05, 2.75]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.039

During the follow-up period (1.1.1998 — 31.12.2019), 1115 out of 6178 males with I9_OTHILLHEART died.

Mortality risk

Mortality risk for people of age

years, who have I9_OTHILLHEART.

N-year risk	Females	Males
1	0.213%	0.452%
5	1.362%	2.737%
10	3.343%	6.988%
15	5.763%	13.198%
20	10.061%	21.709%

Relationships between endpoints

↥

Index endpoint: I9_OTHILLHEART – Other or ill-defined heart diseases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other or ill-defined heart diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints